/**/
RNS Number : 0106G
GoldmanSachs International
17 November 2015
 
Ap27

 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.          KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD ordinary & GDR

Date of dealing

16 November 2015

 

2.          INTERESTS AND SHORT POSITIONS

 

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 


Long

Short


Number


    (%)

Number


(%)

(1) Relevant securities

1,345,728                      (0.02)

43,798                         (0.00)

(2) Derivatives (other than options)

0                                       (0.00)

 0                                   (0.00)

(3) Options and agreements to purchase/sell

0                                       (0.00)

 0                                   (0.00)

Total

1,345,728                      (0.02)

43,798                         (0.00)

 

(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short


Number


(%)

Number


(%)

(1) Relevant securities



(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total




Ap28

 

 

3.       DEALINGS (Note 3)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 4)

Sale (Borrow Partial Return)

129,987

N/A

Sale (Borrow Full Return)

711,582

N/A

Purchase (Borrow New)

865,408

N/A

Purchase (Borrow New)

153,826

N/A

Sale (Borrow Full Return)

153,826

N/A

Purchase (Borrow Adjust)

337

N/A

Purchase (Borrow Adjust)

464

N/A

Purchase (Borrow Adjust)

657

N/A

Purchase (Borrow Adjust)

215

N/A

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)








 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)




 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)




 

 

Ap29

 

OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities
under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.

  

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)                    YES/NO

 

 

Date of disclosure

17 November  2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 9)

Advisor to Offeror

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAAFXFEKSFFF
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Pfizer.
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Pfizer.